Clinical trial
Study on Bioequivalence of Pramipexole Dihydrochloride Sustained Release Tablets
NCT04275492 is registered in ClinicalTrials.gov with First Affiliated Hospital of Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Bioequivalence of Pramipexole Dihydrochloride Sustained Release Tablets
- Lead sponsor
- First Affiliated Hospital of Zhejiang University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 24, 2020
- Completion date
- December 1, 2020
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease